Search research articles
Contact Us
Filters
Showing results (101-110 of 760) with videos related to
Page
of 76
Sort By:
European Heart Journal
|
July 21, 2022
Optimal antiplatelet therapy in patients at high bleeding risk undergoing complex percutaneous coronary intervention
Luis Ortega-Paz, Dominick J Angiolillo
American Heart Journal
|
July 31, 2008
Platelet inhibitor therapy: current perspectives and emerging novel agents: introduction
Dominick J Angiolillo, Eric R Bates
American Heart Journal
|
July 31, 2008
Clinical overview of promising nonthienopyridine antiplatelet agents
Dominick J Angiolillo, Luis A Guzman
Thrombosis and Haemostasis
|
July 3, 2009
Clopidogrel response variability: current status and future directions
José Luis Ferreiro, Dominick J Angiolillo
Coronary Artery Disease
|
June 4, 2021
Septal perforating artery originating from the ramus intermedius artery
Gabriel T Faz, Dominick J Angiolillo
Journal of the American College of Cardiology
|
August 30, 2014
Aspirin treatment and outcomes in patients undergoing percutaneous coronary intervention: is there a role for pharmacodynamic testing?
Dominick J Angiolillo, Jung Rae Cho
Circulation. Cardiovascular Interventions
|
December 19, 2013
Percutaneous coronary interventions in ST-segment-elevation myocardial infarction: shifting paradigms and future perspectives
Dominick J Angiolillo, Theodore A Bass
Circulation
|
February 24, 2011
Diabetes and antiplatelet therapy in acute coronary syndrome
José Luis Ferreiro, Dominick J Angiolillo
Nature Reviews. Cardiology
|
May 28, 2009
Antiplatelet therapy: Clopidogrel plus PPIs-a dangerous combination?
José Luis Ferreiro, Dominick J Angiolillo
Interventional Cardiology Clinics
|
November 26, 2016
Switching P2Y<sub>12</sub> Receptor Inhibiting Therapies
Fabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Page
of 76
Search research articles
Search
Showing results (101-110 of 760) with videos related to
Sort By:
Page
of 76
European Heart Journal
|
July 21, 2022
Optimal antiplatelet therapy in patients at high bleeding risk undergoing complex percutaneous coronary intervention
Luis Ortega-Paz, Dominick J Angiolillo
American Heart Journal
|
July 31, 2008
Platelet inhibitor therapy: current perspectives and emerging novel agents: introduction
Dominick J Angiolillo, Eric R Bates
American Heart Journal
|
July 31, 2008
Clinical overview of promising nonthienopyridine antiplatelet agents
Dominick J Angiolillo, Luis A Guzman
Thrombosis and Haemostasis
|
July 3, 2009
Clopidogrel response variability: current status and future directions
José Luis Ferreiro, Dominick J Angiolillo
Coronary Artery Disease
|
June 4, 2021
Septal perforating artery originating from the ramus intermedius artery
Gabriel T Faz, Dominick J Angiolillo
Journal of the American College of Cardiology
|
August 30, 2014
Aspirin treatment and outcomes in patients undergoing percutaneous coronary intervention: is there a role for pharmacodynamic testing?
Dominick J Angiolillo, Jung Rae Cho
Circulation. Cardiovascular Interventions
|
December 19, 2013
Percutaneous coronary interventions in ST-segment-elevation myocardial infarction: shifting paradigms and future perspectives
Dominick J Angiolillo, Theodore A Bass
Circulation
|
February 24, 2011
Diabetes and antiplatelet therapy in acute coronary syndrome
José Luis Ferreiro, Dominick J Angiolillo
Nature Reviews. Cardiology
|
May 28, 2009
Antiplatelet therapy: Clopidogrel plus PPIs-a dangerous combination?
José Luis Ferreiro, Dominick J Angiolillo
Interventional Cardiology Clinics
|
November 26, 2016
Switching P2Y<sub>12</sub> Receptor Inhibiting Therapies
Fabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Page
of 76